← brief for 2026-11-15 · Slowing decline
Efficacy of SGLT2 Inhibitors in Reducing Cardiovascular Events in Adults with Chronic Kidney Disease, with or without Diabetes: A Systematic Review of Randomized Controlled Trials
Key takeaways
This is a registration for a planned systematic review. It will look at SGLT2 drugs in people with kidney disease. The review is starting, and there are no results yet.
Who did this work
Anna Luisa De Lima Pinto · Victor Barcella
Source
Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-11-14
https://doi.org/10.17605/osf.io/kyb5j